Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 10, 2019 Filed May 13, 2019 21:06 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Tax withholdingCommon Stock | 516 | $78.33 | $40,418.28 |
DisclosureSEC source: 0001104659-19-028977 · a4.xml · nonDerivative · entry 2 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,860.065 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:06 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Exercise / conversionCommon Stock | 1,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-028977 · a4.xml · nonDerivative · entry 1 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,376.065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:06 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,292 | $78.33 | $257,862.36 |
DisclosureSEC source: 0001104659-19-028979 · a4.xml · derivative · entry 3 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,292 shares Expires 2019-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:06 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Tax withholdingCommon Stock | 1,622 | $78.33 | $127,051.26 |
DisclosureSEC source: 0001104659-19-028979 · a4.xml · nonDerivative · entry 2 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,789.972 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:06 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionCommon Stock | 3,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-028979 · a4.xml · nonDerivative · entry 1 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,411.972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2019 Filed May 9, 2019 22:11 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001104659-19-028305 · a4.xml · derivative · entry 4 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,876 Underlying: Common Stock · 25,000 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in three equal installments on 5/2/2013, 5/2/2014 and 5/2/2015. Read SEC document |
| May 07, 2019 Filed May 9, 2019 22:11 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
SaleCommon Stock | 25,000 | $77.73 | $1,943,182.50 |
DisclosureSEC source: 0001104659-19-028305 · a4.xml · nonDerivative · entry 2 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,604.087 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.6400 to $77.8200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 07, 2019 Filed May 9, 2019 22:11 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 25,000 | $39.29 | $982,250.00 |
DisclosureSEC source: 0001104659-19-028305 · a4.xml · nonDerivative · entry 1 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,604.087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2019 Filed May 9, 2019 22:11 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GiftCommon Stock | 14,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-028306 · a4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 783,092.063 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 04, 2019 Filed May 7, 2019 23:37 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,904 | $80.00 | $152,320.00 |
DisclosureSEC source: 0001104659-19-027579 · a4.xml · derivative · entry 5 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,810 Underlying: Common Stock · 1,904 shares Expires 2021-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F5 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. Read SEC document |
| May 04, 2019 Filed May 7, 2019 23:37 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 938 | $80.00 | $75,040.00 |
DisclosureSEC source: 0001104659-19-027579 · a4.xml · nonDerivative · entry 2 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,604.087 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 04, 2019 Filed May 7, 2019 23:37 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 1,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027579 · a4.xml · nonDerivative · entry 1 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,542.087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2019 Filed May 7, 2019 23:40 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,298 | $80.00 | $103,840.00 |
DisclosureSEC source: 0001104659-19-027584 · a4.xml · derivative · entry 5 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,598 Underlying: Common Stock · 1,298 shares Expires 2021-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F5 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. Read SEC document |
| May 04, 2019 Filed May 7, 2019 23:40 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Tax withholdingCommon Stock | 370 | $80.00 | $29,600.00 |
DisclosureSEC source: 0001104659-19-027584 · a4.xml · nonDerivative · entry 2 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,565.065 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 04, 2019 Filed May 7, 2019 23:40 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Exercise / conversionCommon Stock | 1,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027584 · a4.xml · nonDerivative · entry 1 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,935.065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2019 Filed May 7, 2019 23:42 UTC |
Zachary JenniferEVP, General Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,772 | $80.00 | $461,760.00 |
DisclosureSEC source: 0001104659-19-027588 · a4.xml · derivative · entry 4 Zachary Jennifer · CIK 0001737231 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,544 Underlying: Common Stock · 5,772 shares Expires 2021-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. Read SEC document |
| May 04, 2019 Filed May 7, 2019 23:42 UTC |
Zachary JenniferEVP, General Counsel
|
Tax withholdingCommon Stock | 2,154 | $80.00 | $172,320.00 |
DisclosureSEC source: 0001104659-19-027588 · a4.xml · nonDerivative · entry 2 Zachary Jennifer · CIK 0001737231 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,618 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 04, 2019 Filed May 7, 2019 23:42 UTC |
Zachary JenniferEVP, General Counsel
|
Exercise / conversionCommon Stock | 5,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027588 · a4.xml · nonDerivative · entry 1 Zachary Jennifer · CIK 0001737231 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2019 Filed May 8, 2019 00:32 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,212 | $80.00 | $96,960.00 |
DisclosureSEC source: 0001104659-19-027600 · a4.xml · derivative · entry 4 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,424 Underlying: Common Stock · 1,212 shares Expires 2021-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. Read SEC document |
| May 04, 2019 Filed May 8, 2019 00:32 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Tax withholdingCommon Stock | 597 | $80.00 | $47,760.00 |
DisclosureSEC source: 0001104659-19-027600 · a4.xml · nonDerivative · entry 2 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,119.972 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 04, 2019 Filed May 8, 2019 00:32 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionCommon Stock | 1,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027600 · a4.xml · nonDerivative · entry 1 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,716.972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2019 Filed May 8, 2019 00:32 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 692 | $80.00 | $55,360.00 |
DisclosureSEC source: 0001104659-19-027601 · a4.xml · derivative · entry 4 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,386 Underlying: Common Stock · 692 shares Expires 2021-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. Read SEC document |
| May 04, 2019 Filed May 8, 2019 00:32 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Tax withholdingCommon Stock | 238 | $80.00 | $19,040.00 |
DisclosureSEC source: 0001104659-19-027601 · a4.xml · nonDerivative · entry 2 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,807.829 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 04, 2019 Filed May 8, 2019 00:32 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Exercise / conversionCommon Stock | 692 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027601 · a4.xml · nonDerivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,045.829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2019 Filed May 7, 2019 23:37 UTC |
Chattopadhyay SanatExe V-P & Pres. MMD
|
GrantStock Option (right to buy) · Derivative | 64,922 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027578 · a4.xml · derivative · entry 2 Chattopadhyay Sanat · CIK 0001670690 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,922 Underlying: Common Stock · 64,922 shares Expires 2029-05-02 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 7, 2019 23:37 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 50,808 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027579 · a4.xml · derivative · entry 4 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,808 Underlying: Common Stock · 50,808 shares Expires 2029-05-02 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 7, 2019 23:38 UTC |
Davis Robert MEvp, Global Svcs & CFO
|
GrantStock Option (right to buy) · Derivative | 112,907 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027580 · a4.xml · derivative · entry 2 Davis Robert M · CIK 0001363076 · Evp, Global Svcs & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,907 Underlying: Common Stock · 112,907 shares Expires 2029-05-02 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 7, 2019 23:38 UTC |
FRAZIER KENNETH CChairman, President & CEO
|
GrantStock Option (right to buy) · Derivative | 423,402 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027581 · a4.xml · derivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,402 Underlying: Common Stock · 423,402 shares Expires 2029-05-02 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 7, 2019 23:39 UTC |
Gerberding Julie L.EVP Strat Comm, GI Pub Policy
|
GrantStock Option (right to buy) · Derivative | 28,227 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027582 · a4.xml · derivative · entry 2 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, GI Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,227 Underlying: Common Stock · 28,227 shares Expires 2029-05-02 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 7, 2019 23:39 UTC |
MIZELL STEVENEVP,Human Resources
|
GrantStock Option (right to buy) · Derivative | 50,808 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027583 · a4.xml · derivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,808 Underlying: Common Stock · 50,808 shares Expires 2029-05-02 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 7, 2019 23:40 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
GrantStock Option (right to buy) · Derivative | 45,163 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027584 · a4.xml · derivative · entry 4 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,163 Underlying: Common Stock · 45,163 shares Expires 2029-05-02 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 7, 2019 23:41 UTC |
PERLMUTTER ROGER MExe V-P & Pres, MRL
|
GrantStock Option (right to buy) · Derivative | 141,134 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027586 · a4.xml · derivative · entry 2 PERLMUTTER ROGER M · CIK 0001184228 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,134 Underlying: Common Stock · 141,134 shares Expires 2029-05-02 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 7, 2019 23:41 UTC |
Scholefield James HEVP,Chief Info&Digital Officer
|
GrantStock Option (right to buy) · Derivative | 39,518 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027587 · a4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,518 Underlying: Common Stock · 39,518 shares Expires 2029-05-02 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 7, 2019 23:42 UTC |
Zachary JenniferEVP, General Counsel
|
GrantStock Option (right to buy) · Derivative | 66,333 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027588 · a4.xml · derivative · entry 3 Zachary Jennifer · CIK 0001737231 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,333 Underlying: Common Stock · 66,333 shares Expires 2029-05-02 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 8, 2019 00:32 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
GrantRestricted Stock Unit · Derivative | 2,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027600 · a4.xml · derivative · entry 5 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,625 Underlying: Common Stock · 2,625 shares Expires 2022-05-03 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F5 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 8, 2019 00:32 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
GrantStock Option (right to buy) · Derivative | 19,759 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027600 · a4.xml · derivative · entry 3 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,759 Underlying: Common Stock · 19,759 shares Expires 2029-05-02 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 8, 2019 00:32 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
GrantRestricted Stock Unit · Derivative | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027601 · a4.xml · derivative · entry 5 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2022-05-03 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F5 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 8, 2019 00:32 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
GrantStock Option (right to buy) · Derivative | 11,291 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027601 · a4.xml · derivative · entry 3 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,291 Underlying: Common Stock · 11,291 shares Expires 2029-05-02 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 8, 2019 00:33 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
|
Exercise / conversionStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001104659-19-027602 · a4.xml · derivative · entry 5 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,126 Underlying: Common Stock · 35,000 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015. Read SEC document |
| May 03, 2019 Filed May 8, 2019 00:33 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
|
GrantStock Option (right to buy) · Derivative | 56,454 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027602 · a4.xml · derivative · entry 4 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,454 Underlying: Common Stock · 56,454 shares Expires 2029-05-02 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 8, 2019 00:33 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
|
SaleCommon Stock | 35,000 | $80.00 | $2,800,000.00 |
DisclosureSEC source: 0001104659-19-027602 · a4.xml · nonDerivative · entry 2 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,064.209 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 03, 2019 Filed May 8, 2019 00:33 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
|
Exercise / conversionCommon Stock | 35,000 | $39.29 | $1,375,150.00 |
DisclosureSEC source: 0001104659-19-027602 · a4.xml · nonDerivative · entry 1 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,064.209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2019 Filed Dec 16, 2019 16:17 UTC Amendment |
Fleming MichaelSVP Chief Ethics & Com Officer
|
GrantRestricted Stock Unit · Derivative | 4,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-034976 · form4a.xml · derivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,625 Underlying: Common Stock · 4,625 shares Expires 2022-05-03 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2 · shares: The original Form 4, filed on May 7, 2019, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the number of restricted stock units granted on May 3, 2019. As a result of this administrative error, the number of restricted stock units granted to the reporting person following the corrected transaction reflects an increase by 3,125 shares in the number of restricted stock units reported. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. F2 · derivative.underlying_shares: The original Form 4, filed on May 7, 2019, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the number of restricted stock units granted on May 3, 2019. As a result of this administrative error, the number of restricted stock units granted to the reporting person following the corrected transaction reflects an increase by 3,125 shares in the number of restricted stock units reported. F2 · balance_after: The original Form 4, filed on May 7, 2019, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the number of restricted stock units granted on May 3, 2019. As a result of this administrative error, the number of restricted stock units granted to the reporting person following the corrected transaction reflects an increase by 3,125 shares in the number of restricted stock units reported. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:58 UTC |
Coe Mary EllenDirector
|
GrantPhantom Stock · Derivative | 56.5625 | $83.17 | $4,704.30 |
DisclosureSEC source: 0001225208-19-006167 · doc4.xml · derivative · entry 2 Coe Mary Ellen · CIK 0001691304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135.2085 Underlying: Common Stock · 56.5625 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:58 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 405.7954 | $83.17 | $33,750.00 |
DisclosureSEC source: 0001225208-19-006168 · doc4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,095.1334 Underlying: Common Stock · 405.7954 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:58 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 345.6775 | $83.17 | $28,750.00 |
DisclosureSEC source: 0001225208-19-006169 · doc4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,615.7065 Underlying: Common Stock · 345.6775 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:58 UTC |
Noseworthy John HDirector
|
GrantPhantom Stock · Derivative | 345.6775 | $83.17 | $28,750.00 |
DisclosureSEC source: 0001225208-19-006170 · doc4.xml · derivative · entry 2 Noseworthy John H · CIK 0001706596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,224.8365 Underlying: Common Stock · 345.6775 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:58 UTC |
THULIN INGE GDirector
|
GrantPhantom Stock · Derivative | 345.6775 | $83.17 | $28,750.00 |
DisclosureSEC source: 0001225208-19-006171 · doc4.xml · derivative · entry 2 THULIN INGE G · CIK 0001263739 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,265.6455 Underlying: Common Stock · 345.6775 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:58 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 345.6775 | $83.17 | $28,750.00 |
DisclosureSEC source: 0001225208-19-006172 · doc4.xml · derivative · entry 2 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,376.8155 Underlying: Common Stock · 345.6775 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:58 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 345.6775 | $83.17 | $28,750.00 |
DisclosureSEC source: 0001225208-19-006173 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,429.8975 Underlying: Common Stock · 345.6775 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.